Literature DB >> 21392994

Novel ancestral Dysferlin splicing mutation which migrated from the Iberian peninsula to South America.

Luis Vernengo1, Jorge Oliveira, Martin Krahn, Emilia Vieira, Rosário Santos, Luisa Carrasco, Luís Negrão, Ana Panuncio, France Leturcq, Veronique Labelle, Elsa Bronze-da-Rocha, Rosario Mesa, Carlos Pizzarossa, Nicolas Lévy, Maria-Mirta Rodriguez.   

Abstract

Primary dysferlinopathies are a group of recessive heterogeneous muscular dystrophies. The most common clinical presentations are Miyoshi myopathy and LGMD2B. Additional presentations range from isolated hyperCKemia to severe functional disability. Symptomatology begins in the posterior muscle compartment of the calf and its clinical course progresses slowly in Miyoshi myopathy whereas LGMD2B involves predominantly the proximal muscles of the lower limbs. The age of onset ranges from 13 to 60years in Caucasians. We present five patients that carry a novel mutation in the exon12/intron12 boundary: c.1180_1180+7delAGTGCGTG (r.1054_1284del). We provide evidence of a founder effect due to a common ancestral origin of this mutation, detected in heterozygosity in four patients and in homozygosity in one patient.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392994     DOI: 10.1016/j.nmd.2011.02.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

Review 1.  Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.

Authors:  Cecilia Contreras-Cubas; Francisco Barajas-Olmos; Maria Inés Frayre-Martínez; Georgina Siordia-Reyes; Claudia C Guízar-Sánchez; Humberto García-Ortiz; Lorena Orozco; Vicente Baca
Journal:  BMC Med Genomics       Date:  2022-06-20       Impact factor: 3.622

Review 2.  Limb-girdle Muscular Dystrophies in India: A Review.

Authors:  Satish V Khadilkar; Hinaben Dayalal Faldu; Sarika Bapuso Patil; Rakesh Singh
Journal:  Ann Indian Acad Neurol       Date:  2017 Apr-Jun       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.